IL9 and cancer: The Tc9-specific antitumor action of IL-9 involves self-activation of IL-9 receptors, which, via STAT3 activation, promote lipid peroxidation (LPO) or fatty acid oxidation (FAO) for their energy requirements and escape cancer cell-induced ferroptosis to exert antitumor action [227].